Results 201 to 210 of about 5,071,260 (360)
ANGIOMATOSIS, WITH LESIONS OF THE SKIN AND MUCOUS MEMBRANE. [PDF]
JAY FRANK SCHAMBERG
openalex +1 more source
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li+12 more
wiley +1 more source
Basement membrane perforations guide anterior-posterior axis formation. [PDF]
Chen DY+9 more
europepmc +1 more source
Note on pathological changes found in the embryo pig and its membranes [PDF]
Henry S. Denison
openalex +1 more source
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi+12 more
wiley +1 more source
Fabrication of Green PVDF/TiO<sub>2</sub> Composite Membrane for Water Treatment. [PDF]
Lu S, Zou D.
europepmc +1 more source
Poly(aryl piperidinium) membranes and ionomers for hydroxide exchange membrane fuel cells
Junhua Wang+12 more
semanticscholar +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza+3 more
wiley +1 more source
Evaluating the Performance of Gravity-Driven Membrane Filtration for Waterborne Pathogen Removal and Public Health Protection. [PDF]
Li C.
europepmc +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source